Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Baculovirus-based display and gene delivery systems.

Mäkelä AR, Ernst W, Grabherr R, Oker-Blom C.

Cold Spring Harb Protoc. 2010 Mar;2010(3):pdb.top72. doi: 10.1101/pdb.top72. Review.

PMID:
20194476
2.

Monitoring baculovirus-mediated efficiency of gene delivery.

Mäkelä AR, Ernst W, Grabherr R, Oker-Blom C.

Cold Spring Harb Protoc. 2010 Mar;2010(3):pdb.prot5397. doi: 10.1101/pdb.prot5397.

PMID:
20194466
3.

Immunoelectron microscopy analysis of recombinant baculovirus display viruses.

Mäkelä AR, Ernst W, Grabherr R, Oker-Blom C.

Cold Spring Harb Protoc. 2010 Mar;2010(3):pdb.prot5396. doi: 10.1101/pdb.prot5396.

PMID:
20194465
4.

Immunofluorescence analysis of baculovirus-displayed viral proteins on infected insect cells.

Mäkelä AR, Ernst W, Grabherr R, Oker-Blom C.

Cold Spring Harb Protoc. 2010 Mar;2010(3):pdb.prot5395. doi: 10.1101/pdb.prot5395.

PMID:
20194464
5.

Determination of recombinant baculovirus display viral titer.

Mäkelä AR, Ernst W, Grabherr R, Oker-Blom C.

Cold Spring Harb Protoc. 2010 Mar;2010(3):pdb.prot5394. doi: 10.1101/pdb.prot5394.

PMID:
20194463
6.

Creation of baculovirus display libraries.

Mäkelä AR, Ernst W, Grabherr R, Oker-Blom C.

Cold Spring Harb Protoc. 2010 Mar;2010(3):pdb.prot5393. doi: 10.1101/pdb.prot5393.

PMID:
20194462
7.

Desipramine induces disorder in cholesterol-rich membranes: implications for viral trafficking.

Pakkanen K, Salonen E, Mäkelä AR, Oker-Blom C, Vattulainen I, Vuento M.

Phys Biol. 2009 Sep 10;6(4):046004. doi: 10.1088/1478-3975/6/4/046004.

PMID:
19741281
8.

Early succession of bacterial biofilms in paper machines.

Tiirola M, Lahtinen T, Vuento M, Oker-Blom C.

J Ind Microbiol Biotechnol. 2009 Jul;36(7):929-37. doi: 10.1007/s10295-009-0571-6. Epub 2009 Apr 24.

PMID:
19390885
9.

Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells.

Laakkonen JP, Mäkelä AR, Kakkonen E, Turkki P, Kukkonen S, Peränen J, Ylä-Herttuala S, Airenne KJ, Oker-Blom C, Vihinen-Ranta M, Marjomäki V.

PLoS One. 2009;4(4):e5093. doi: 10.1371/journal.pone.0005093. Epub 2009 Apr 7.

10.

Parvovirus capsid disorders cholesterol-rich membranes.

Pakkanen K, Kirjavainen S, Mäkelä AR, Rintanen N, Oker-Blom C, Jalonen TO, Vuento M.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):562-6. doi: 10.1016/j.bbrc.2008.12.116. Epub 2008 Dec 30.

PMID:
19118523
11.

Method and apparatus using selected superparamagnetic labels for rapid quantification of immunochromatographic tests.

Laitinen MP, Salmela J, Gilbert L, Kaivola R, Tikkala T, Oker-Blom C, Pekola J, Vuento M.

Nanotechnol Sci Appl. 2009 Apr 14;2:13-20. eCollection 2009.

12.

Tumor targeting of baculovirus displaying a lymphatic homing peptide.

Mäkelä AR, Enbäck J, Laakkonen JP, Vihinen-Ranta M, Laakkonen P, Oker-Blom C.

J Gene Med. 2008 Sep;10(9):1019-31. doi: 10.1002/jgm.1222.

PMID:
18655234
13.

Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.

Michel PO, Mäkelä AR, Korhonen E, Toivola J, Hedman L, Söderlund-Venermo M, Hedman K, Oker-Blom C.

J Virol Methods. 2008 Sep;152(1-2):1-5. doi: 10.1016/j.jviromet.2008.06.006. Epub 2008 Jul 16.

PMID:
18598721
14.

Occlusion-derived baculovirus: interaction with human cells and evaluation of the envelope protein P74 as a surface display platform.

Mäkelä AR, Tuusa JE, Volkman LE, Oker-Blom C.

J Biotechnol. 2008 Jun 1;135(2):145-56. doi: 10.1016/j.jbiotec.2008.03.014. Epub 2008 Apr 7.

PMID:
18471919
15.

The baculovirus display technology--an evolving instrument for molecular screening and drug delivery.

Mäkelä AR, Oker-Blom C.

Comb Chem High Throughput Screen. 2008 Feb;11(2):86-98. Review.

PMID:
18336202
16.

Peptide-mediated interference with baculovirus transduction.

Mäkelä AR, Närvänen A, Oker-Blom C.

J Biotechnol. 2008 Mar 20;134(1-2):20-32. doi: 10.1016/j.jbiotec.2007.12.010. Epub 2008 Jan 18.

PMID:
18294718
17.

Hydrophobin (HFBI): A potential fusion partner for one-step purification of recombinant proteins from insect cells.

Lahtinen T, Linder MB, Nakari-Setälä T, Oker-Blom C.

Protein Expr Purif. 2008 May;59(1):18-24. doi: 10.1016/j.pep.2007.12.014. Epub 2008 Jan 11.

PMID:
18267368
18.

Evaluation of a new ELISA for the detection of specific IgG to the Epstein-Barr nuclear antigen 1 (EBNA-1).

Schenk BI, Michel PO, Enders G, Thilo N, Radtke M, Oker-Blom C, Franke D.

Clin Lab. 2007;53(3-4):151-5.

PMID:
17447651
19.

Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles.

Gilbert L, Toivola J, Välilehto O, Saloniemi T, Cunningham C, White D, Mäkelä AR, Korhonen E, Vuento M, Oker-Blom C.

J Nanobiotechnology. 2006 Dec 8;4:13.

20.
21.

Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides.

Mäkelä AR, Matilainen H, White DJ, Ruoslahti E, Oker-Blom C.

J Virol. 2006 Jul;80(13):6603-11.

22.

Improving baculovirus transduction of mammalian cells by surface display of a RGD-motif.

Ernst W, Schinko T, Spenger A, Oker-Blom C, Grabherr R.

J Biotechnol. 2006 Nov 1;126(2):237-40. Epub 2006 May 22.

PMID:
16716431
23.

RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells.

Matilainen H, Mäkelä AR, Riikonen R, Saloniemi T, Korhonen E, Hyypiä T, Heino J, Grabherr R, Oker-Blom C.

J Biotechnol. 2006 Aug 20;125(1):114-26. Epub 2006 Mar 29.

PMID:
16569454
24.

Diversity of bacteria contaminating paper machines.

Lahtinen T, Kosonen M, Tiirola M, Vuento M, Oker-Blom C.

J Ind Microbiol Biotechnol. 2006 Sep;33(9):734-40. Epub 2006 Mar 7.

PMID:
16520979
25.

Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1.

Magga J, Bart G, Oker-Blom C, Kukkonen JP, Akerman KE, Näsman J.

Biochem Pharmacol. 2006 Mar 14;71(6):827-36. Epub 2006 Jan 20.

PMID:
16430869
26.

Disassembly of structurally modified viral nanoparticles: characterization by fluorescence correlation spectroscopy.

Toivola J, Gilbert L, Michel P, White D, Vuento M, Oker-Blom C.

C R Biol. 2005 Dec;328(12):1052-6. Epub 2005 Oct 24.

PMID:
16314283
27.

Baculovirus entry into human hepatoma cells.

Matilainen H, Rinne J, Gilbert L, Marjomäki V, Reunanen H, Oker-Blom C.

J Virol. 2005 Dec;79(24):15452-9.

28.

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

Franssila R, Auramo J, Modrow S, Möbs M, Oker-Blom C, Käpylä P, Söderlund-Venermo M, Hedman K.

Clin Exp Immunol. 2005 Oct;142(1):53-61.

29.

Functional display of an alpha2 integrin-specific motif (RKK) on the surface of baculovirus particles.

Riikonen R, Matilainen H, Rajala N, Pentikainen O, Johnson M, Heino J, Oker-Blom C.

Technol Cancer Res Treat. 2005 Aug;4(4):437-45.

PMID:
16029062
30.

Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.

Gilbert L, Toivola J, White D, Ihalainen T, Smith W, Lindholm L, Vuento M, Oker-Blom C.

Biochem Biophys Res Commun. 2005 Jun 3;331(2):527-35.

PMID:
15850791
31.

Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cells.

Gilbert L, Välilehto O, Kirjavainen S, Tikka PJ, Mellett M, Käpylä P, Oker-Blom C, Vuento M.

FEBS Lett. 2005 Jan 17;579(2):385-92.

32.

Expression and trafficking of fluorescent viral membrane proteins in baculovirus-transduced BHK cells.

Ojala K, Tikka PJ, Kautto L, Käpylä P, Marjomäki V, Oker-Blom C.

J Biotechnol. 2004 Oct 19;114(1-2):165-75.

PMID:
15464610
33.

Baculovirus display strategies: Emerging tools for eukaryotic libraries and gene delivery.

Oker-Blom C, Airenne KJ, Grabherr R.

Brief Funct Genomic Proteomic. 2003 Oct;2(3):244-53. Review.

PMID:
15239927
34.

Monitoring human parvovirus B19 virus-like particles and antibody complexes in solution by fluorescence correlation spectroscopy.

Toivola J, Michel PO, Gilbert L, Lahtinen T, Marjomäki V, Hedman K, Vuento M, Oker-Blom C.

Biol Chem. 2004 Jan;385(1):87-93.

PMID:
14977050
35.

Improved display of synthetic IgG-binding domains on the baculovirus surface.

Ojala K, Koski J, Ernst W, Grabherr R, Jones I, Oker-Blom C.

Technol Cancer Res Treat. 2004 Feb;3(1):77-84.

PMID:
14750896
36.

Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells.

Gilbert L, Toivola J, Lehtomäki E, Donaldson L, Käpylä P, Vuento M, Oker-Blom C.

Biochem Biophys Res Commun. 2004 Jan 23;313(4):878-87.

PMID:
14706624
37.

Reconstitution of recombinant viral envelope proteins.

Oker-Blom C, Vuento M.

Methods Enzymol. 2003;372:418-28. No abstract available.

PMID:
14610828
38.

Baculovirus capsid display: a novel tool for transduction imaging.

Kukkonen SP, Airenne KJ, Marjomäki V, Laitinen OH, Lehtolainen P, Kankaanpää P, Mähönen AJ, Räty JK, Nordlund HR, Oker-Blom C, Kulomaa MS, Ylä-Herttuala S.

Mol Ther. 2003 Nov;8(5):853-62.

39.

Properties of baculovirus particles displaying GFP analyzed by fluorescence correlation spectroscopy.

Toivola J, Ojala K, Michel PO, Vuento M, Oker-Blom C.

Biol Chem. 2002 Dec;383(12):1941-6.

PMID:
12553731
40.

Interaction of neuronal calcium sensor-1 (NCS-1) with phosphatidylinositol 4-kinase beta stimulates lipid kinase activity and affects membrane trafficking in COS-7 cells.

Zhao X, Várnai P, Tuymetova G, Balla A, Tóth ZE, Oker-Blom C, Roder J, Jeromin A, Balla T.

J Biol Chem. 2001 Oct 26;276(43):40183-9. Epub 2001 Aug 28.

41.

Maturation of IgG avidity to individual rubella virus structural proteins.

Nedeljkovic J, Jovanovic T, Oker-Blom C.

J Clin Virol. 2001 Aug;22(1):47-54.

PMID:
11418352
42.

Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.

Ojala K, Mottershead DG, Suokko A, Oker-Blom C.

Biochem Biophys Res Commun. 2001 Jun 15;284(3):777-84.

PMID:
11396970
43.

Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins.

Grabherr R, Ernst W, Oker-Blom C, Jones I.

Trends Biotechnol. 2001 Jun;19(6):231-6. Review.

PMID:
11356285
44.

Expression and glycosylation studies of human FGF receptor 4.

Tuominen H, Heikinheimo P, Loo BM, Kataja K, Oker-Blom C, Uutela M, Jalkanen M, Goldman A.

Protein Expr Purif. 2001 Mar;21(2):275-85.

PMID:
11237689
45.
46.

Baculoviral display of functional scFv and synthetic IgG-binding domains.

Mottershead DG, Alfthan K, Ojala K, Takkinen K, Oker-Blom C.

Biochem Biophys Res Commun. 2000 Aug 18;275(1):84-90.

PMID:
10944446
47.

A streptavidin-luciferase fusion protein: comparisons and applications.

Karp M, Oker-Blom C.

Biomol Eng. 1999 Dec 31;16(1-4):101-4. Review.

PMID:
10796991
48.

Mimicking rubella virus particles by using recombinant envelope glycoproteins and liposomes.

Orellana A, Mottershead D, van der Linden I, Keinänen K, Oker-Blom C.

J Biotechnol. 1999 Oct 8;75(2-3):209-19.

PMID:
10553659
49.

Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells.

Nedeljkovic J, Jovanovic T, Mladjenovic S, Hedman K, Peitsaro N, Oker-Blom C.

J Clin Virol. 1999 Oct;14(2):119-31.

PMID:
10588454
50.

Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.

Kaikkonen L, Lankinen H, Harjunpää I, Hokynar K, Söderlund-Venermo M, Oker-Blom C, Hedman L, Hedman K.

J Clin Microbiol. 1999 Dec;37(12):3952-6. Erratum in: J Clin Microbiol 2000 Feb;38(2):944.

Supplemental Content

Loading ...
Support Center